Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- HM
- Uo
- MU
Lists including Elizabeth
Investments
Work Experience
Cd
2024
Board Member
2024
2023
President & CEO
2023
2011
Founder
2011
AmorChem is a leading early-stage venture capital investing in research innovation and creating next-gen biotech companies in life sciences. The fund has 95M$ under management for pre-seed, seed and Series A investments.
2016
Chair
2019
Board Member
2016 - 2019
2017
Board Member
2017
Corbin Therapeutics develops USP15 inhibitors to treat and manage neuroinflamation.
Member
2016
2018
Board Member
2020
SemaThera develops anti-SEMA3A biologics to treat diabetic macular edema.
Board Observer
2018 - 2020
2018 - 2022
Board Observer
2018 - 2022
Inversago Pharma develops next gen CB1 inverse agonists to treat Prader-Willi Syndrome
2015 - 2020
Board Member
2015 - 2020
2013 - 2018
Board Member
2013 - 2018